Table 2.
Drug name | National projection in millions | Percentage of treated patients on this medication |
---|---|---|
ACEIs | 27.1 | 28.5% |
Lisinopril | 20.8 | 21.9% |
Benazepril | 2.8 | 2.9% |
Enalapril | 1.3 | 1.4% |
Ramipril | 1.0 | 1.0% |
Quinapril | 0.7 | 0.7% |
Other | 0.5 | 0.5% |
Thiazides | 23.0 | 24.2% |
Hydrochlorothiazide | 21.1 | 22.2% |
Chlorthalidone | 1.0 | 1.1% |
Other | 0.9 | 0.9% |
ARBs | 20.4 | 21.5% |
Losartan | 9.0 | 9.4% |
Olmesartan | 4.9 | 5.1% |
Valsartan | 4.1 | 4.3% |
Irbesartan | 0.8 | 0.9% |
Telmisartan | 0.7 | 0.7% |
Other | 1.0 | 1.0% |
CCBs | 20.1 | 21.1% |
Amlodipine | 16.8 | 17.7% |
Diltiazem | 1.5 | 1.6% |
Verapamil | 0.8 | 0.8% |
Nifedipine | 0.8 | 0.8% |
Other | 0.2 | 0.2% |
Beta blockers | 17.8 | 18.7% |
Metoprolol | 7.9 | 8.3% |
Atenolol | 3.9 | 4.1% |
Nebivolol | 2.1 | 2.2% |
Carvedilol | 2.0 | 2.1% |
Bisoprolol | 0.7 | 0.8% |
Labetalol | 0.5 | 0.5% |
Other | 0.6 | 0.7% |
Nonthiazide diuretics | 4.1 | 4.3% |
Triamterene | 2.0 | 2.1% |
Furosemide | 1.0 | 1.0% |
Other | 0.6 | 0.6% |
Central acting agents | 1.4 | 1.5% |
Clonidine | 1.3 | 1.4% |
Other | 0.1 | 0.1% |
Vasodilators | 0.7 | 0.7% |
Hydralazine | 0.6 | 0.6% |
Other | 0.0 | 0.1% |
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium-channel blockers.
Source: QuintilesIMS, NDTI, 2014.